The arm can be tucked under surgical drape, no thumb access requiredicon-tickLess than 30 seconds start-up, no calibration needed icon-tickEase of use with single-use electro-sensors and no cross-contamination icon-tickPrecise & reliable information based on EMG technique The new TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents (NMBAs). The sequence is performed in real-time, and the system requires less than 30 sec. for set-up.
The unique, user-friendly system includes the TetraGraph monitor, TetraSens disposable electrosensors and the TetraCord connecting cable.
Product category: Patient monitoring systems / Measuring stations
The next generation of patient monitoring
Detects early signs of complicationsicon-tickEnables early diagnosis icon-tickImproves treatment icon-tickReduces hospital stays and health care costs
The CliniSenz Analyzer is the future for postoperative monitoring since the analyzer provides continuous unattended monitoring of patients and only requires small sample volumes for analysis. The results are specific and have high precision as the CliniSenz Analyzer works with enzyme-based heat flow detection integrated on a proprietary microfluidic chip. Interferences from other substances such as pharmaceuticals are thereby avoided. CliniSenz Analyzer is used together with OnZurf Probe and other types of microdialysis catheters.
Specific and fast sampling from the surface of an organ
Continous samplingicon-tickCollect biomarkers icon-tickMinor invasive icon-tickMinor stress to the organ Onzurf Probe is based on the microdialysis technique and is an advanced development of the commercial probes already in clinical use. The Onzurf Probe has a unique attachment site, which allows the probe to be easily placed on the surface of an organ without penetrating the tissue and causing unnecessary stress to the organ. Previous preclinical studies have demonstrated that measurements from the heart, liver and intestinal surface reflect the metabolic processes that occur in the heart muscle, the liver parenchyma and intestinal lumen.
OnZurf Probe is used mainly for postoperative continuous sampling of substances that can be measured with CliniSenz Analyzer. The technology also allows the use of the OnZurf Probe as a continuous microdialysis sampler in clinical and preclinical studies together with Clinisenz Analyzer or other analytical systems, such as HPLC (high-performance liquid chromatography).
Senzimes solutions are designed to ensure maximum patient benefiticon-tickReduce complications associated with surgery icon-tickReduce health care costs Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients neuromuscular function perioperatively and in the intensive care medicine setting.
The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The Senzime AB (publ) share are listed on NASDAQ Stockholm First North. Short name: SEZI.